As of 2024-12-12, the Fair Value of NextCell Pharma AB (NXTCL.ST) is -2.87 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.74 SEK, the upside of NextCell Pharma AB is -264.96%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | 5Y Avg | |
| Net income | -17.68 | -24.56 | -34.55 | -39.81 | -41.96 | -31.71 |
| YoY growth | 1.76% | -38.89% | -40.71% | -15.21% | -5.40% | -19.69% |
| Market Cap (mil) | 127.18 |
| P/E | |
| Forward P/E |
| EPS | -0.57 |
| Avg earnings growth rate | -19.69% |
| TTM earnings | -41.96 |